Alambic Investment Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Alambic Investment Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-123,910	Closed	-$1.74M	–	530
2017 Q3	$1.74M	Sell	123,910 -41,091	-25%	-$372K	0.19%	178
2017 Q2	$1.23M	Sell	165,001 -122,600	-43%	-$801K	0.15%	229
2017 Q1	$1.87M	Buy	287,601 +2,500	+0.9%	+$14K	0.23%	150
2016 Q4	$1.26M	Sell	285,101 -10,500	-4%	-$44K	0.22%	160
2016 Q3	$1.38M	Buy	295,601 +99,600	+51%	+$590K	0.32%	99
2016 Q2	$1.29M	Buy	196,001 +83,101	+74%	+$587K	0.32%	89
2016 Q1	$718K	Buy	112,900 +18,600	+20%	+$95.4K	0.23%	161
2015 Q4	$569K	Buy	+94,300	New	+$539K	0.34%	102

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alambic Investment Management's SPPI Position: Q4 2017 in Review

Alambic Investment Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2017, closing a stake of 123,910 shares — an estimated $1.74M sold.

Alambic Investment Management first reported a position in SPPI in Q4 2015 and held it in 8 quarters. The position peaked at $1.87M in Q1 2017. 157 funds tracked by Wall St. Rank hold SPPI as of Q4 2017.

Alambic Investment Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Alambic Investment Management sold 123,910 Spectrum Pharmaceuticals Inc shares in Q4 2017, an estimated $1.74M.
Alambic Investment Management first reported a position in Spectrum Pharmaceuticals Inc in Q4 2015 and held it in 8 quarters.
Alambic Investment Management's Spectrum Pharmaceuticals Inc position peaked at $1.87M in Q1 2017.
157 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2017.

Based on Alambic Investment Management's 13F filing for Q4 2017, filed 2 Feb 2018.